ArticleFrontiers in immunology2025

Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis.

Aline Silva Barreto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.